DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

PURPOSE: Hepatocellular carcinoma (HCC) is refractory cancer with high morbidity and high mortality. DEAH-box polypeptide 32 (DHX32) was upregulated in several types of malignancies and predicted poor prognosis. Herein, we investigated the role of DHX32 in HCC progression. METHODS: The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoyun, Yuan, Guosheng, Li, Qi, Huang, Jing, Cheng, Xiao, Chen, Jinzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971220/
https://www.ncbi.nlm.nih.gov/pubmed/33729094
http://dx.doi.org/10.1080/07853890.2021.1898674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971220/
https://www.ncbi.nlm.nih.gov/pubmed/33729094
http://dx.doi.org/10.1080/07853890.2021.1898674

Ejemplares similares